JB-002

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJB-002
Drug Alias NameJB-002
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungThyroid NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJivana Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJivana Biotechnology Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungThyroid NeoplasmsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A